Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy

Cancer Cell(2024)10.1016/j.ccell.2024.10.009Source: DataRank Database

In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0.484. It has been cited 11 times, with 8 citing works in its 1-hop citation network.

N/A

0.484DataRank · unranked

Scored on demand from live citation data

Open Access11 citations · 8 citing works in its network

Download PDF

Cite:

Linked data & code

geo pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (27 grants)Impact (FWCI 3.28)OA: greenTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 77%Citation Network 23%

Base Score Contribution

0.373

From this paper's citation signal

Citation Network Contribution

0.111

From 8 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 8 citers.

Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations
Cell stem cell202517 citations102 referencesContributes 0.028
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
Nature Reviews Clinical Oncology202479 citations186 referencesContributes 0.024
Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia
Experimental Hematology20251 citations35 referencesContributes 0.020
Ontogeny and transcriptional regulation of Thetis cells
Nature20262 citations73 referencesContributes 0.015
Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia
Neoplasia20251 citations48 referencesContributes 0.014

Authors (35)

Andrew Dunbar ORCID,Tanmay Mishra ORCID,Wenbin Xiao ORCID,Michael R. Waarts ORCID,Inés Fernández-Maestre ORCID

Live enrichment

PubMed:39532065 PMC:PMC11561369 OpenAlex:https://openalex.org/W4404240963

National Institutes of Health

Grant: T32CA009207

American Association for Cancer Research

Grant: 17-40-11-DUNB

National Cancer Institute

Grant: P01 CA108671

US Department of Veterans Affairs

Grant: I01BX005991

Novartis Pharmaceuticals Corporation

Grant: U01AG077925

Novartis Pharmaceuticals Corporation

Grant: R56DK138826

Novartis Pharmaceuticals Corporation

Grant: NIDDK R56

Damon Runyon Cancer Research Foundation

Grant: PST-24-19

NIDDK NIH HHS

Grant: R01 DK118072

NCI NIH HHS

Grant: R00 CA252005

NCI NIH HHS

Grant: R37 CA226433

NCI NIH HHS

Grant: K08 CA267058

NCI NIH HHS

Grant: P30 CA008748

NIGMS NIH HHS

Grant: T32 GM152349

NCI NIH HHS

Grant: K08 CA241371

NCI NIH HHS

Grant: K99 CA248460

NCI NIH HHS

Grant: R35 CA197594

NCI NIH HHS

Grant: K99 CA252005

NCI NIH HHS

Grant: P50 CA254838

NCI NIH HHS

Grant: R00 CA248460

NCI NIH HHS

Grant: R01 CA173636

Leukemia Research Foundation

Marie-Josée and Henry R. Kravis Center for Molecular Oncology

William Raveis Charitable Fund

Memorial Sloan-Kettering Cancer Center

Leukemia and Lymphoma Society

National Institute of Diabetes and Digestive and Kidney Diseases

FWCI

3.28

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11561369/pdf/nihms-2031055.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610824003970?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610824003970?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11561369

Fields of Study

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processesCancer Genomics and Diagnostics

MeSH Terms

DNA Methyltransferase 3ANucleophosminAnimalsCell Transformation, NeoplasticDNA (Cytosine-5-)-MethyltransferasesHumansIsocitrate DehydrogenaseMutationNuclear ProteinsMutagenesisHematologic NeoplasmsMicefms-Like Tyrosine Kinase 3Carcinogenesis

Keywords

CarcinogenesisHaematopoiesisMalignancyCancer researchBiologyIn vivoDependency (UML)Computational biologyHematologic malignancyCancerGeneticsStem cellMedicineComputer scienceInternal medicineLeukemiaGenetically Engineered Mouse ModelsSequential MutagenesisOncogene Dependency

Sustainable Development Goals

SDG 0: Zero hunger

Related Papers (2)

Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity

N/A

0.827DataRank · unranked

Leukemia(2024)

co-cited

10.1038/s41375-024-02211-z

Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML

N/A

2.3DataRank · unranked

JCI Insight(2020)

co-cited

10.1172/jci.insight.142149

In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (35)

Funding (27 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (2)